Business Wire

MA-ADVENT-TECHNOLOGIES

20.9.2022 02:25:27 CEST | Business Wire | Press release

Share
Advent Technologies signs Supply Agreement with the German State of Brandenburg for Fuel Cell Systems

Advent Technologies Holdings, Inc. (NASDAQ: ADN) ("Advent" or the "Company"), an innovation-driven leader in the fuel cell and hydrogen technology sectors, is pleased to announce the signing of a three-year agreement with the German State of Brandenburg for the supply of methanol-powered fuel cell systems, which will be installed in select critical communication sites in the region.

Advent's methanol-powered fuel cell systems will be used as a back-up power source for Brandenburg's BOS digital radio network, replacing the diesel-driven emergency power systems at several sites over the next three years. Germany's old public safety and security infrastructure relied on an outdated analogue radio system for communication. BOS is a digital, encrypted, and secure means of communication. The new BOS network allows first responders and other public safety officials to communicate easily and securely. The BOS network now covers 99.2% of German territory.

Advent's solution was selected as part of a tender launched by the German State of Brandenburg, which requested that fuel cell and hydrogen technology companies submit proposals for sustainable and reliable emergency power supply solutions. Prior to Advent's selection, the performance of the Company's methanol-powered fuel cells was tested at a site of the BOS digital radio network in Brandenburg, providing further proof of concept for the use of HT-PEM fuel cells as an efficient back-up power source for critical infrastructure applications. Advent's methanol-powered fuel cells deliver reliable power in an environmentally friendly way – reducing CO2 emissions and operating silently – while having a low impact on the surroundings. Methanol, as a carrier of hydrogen, allows simpler storage than pure hydrogen and enhances the safety of operations.

"We are thrilled that the German State of Brandenburg endorses Advent’s products for Brandenburg’s critical communication needs and are confident that Advent’s methanol-powered fuel cell systems will ensure the seamless operation of the entire BOS digital radio network in the region. This new partnership marks a major step towards the wider adoption of HT-PEM fuel cells as a back-up power source in critical infrastructure applications across Europe. We look forward to joining similar projects in the near future,” stated Advent Technologies GmbH Senior Vice President, Daniel Hennig.

"The Advent team is proud and excited to start this new collaboration with the German State of Brandenburg. Now, more than ever, the world needs zero-emission back-up power solutions to ensure a clean and uninterrupted energy supply. Today's agreement is another testament on how Advent’s methanol-powered fuel cells can play a major role in supporting critical infrastructure power requirements around the globe. We look forward to a long and successful collaboration with our new partner," added Dr. Vasilis Gregoriou, Advent Technologies Chief Executive Officer and Executive Chairman of the Board.

About Advent Technologies Holdings, Inc.

Advent Technologies Holdings, Inc. is a U.S. corporation that develops, manufactures, and assembles complete fuel cell systems as well as supplying customers with critical components for fuel cells in the renewable energy sector. Advent is headquartered in Boston, Massachusetts, with offices in California, Greece, Denmark, Germany, and the Philippines. With more than 150 patents issued, pending, and/or licensed for fuel cell technology, Advent holds the IP for next-generation HT-PEM that enables various fuels to function at high temperatures and under extreme conditions – offering a flexible fuel option for the automotive, aviation, defense, oil and gas, marine, and power generation sectors. For more information, visit www.advent.energy.

Cautionary Note Regarding Forward-Looking Statements

This press release includes forward-looking statements. These forward-looking statements generally can be identified by the use of words such as “anticipate,” “expect,” “plan,” “could,” “may,” “will,” “believe,” “estimate,” “forecast,” “goal,” “project,” and other words of similar meaning. Each forward-looking statement contained in this press release is subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statement. Applicable risks and uncertainties include, among others, the Company’s ability to maintain the listing of the Company’s common stock on Nasdaq; future financial performance; public securities’ potential liquidity and trading; impact from the outcome of any known and unknown litigation; ability to forecast and maintain an adequate rate of revenue growth and appropriately plan its expenses; expectations regarding future expenditures; future mix of revenue and effect on gross margins; attraction and retention of qualified directors, officers, employees and key personnel; ability to compete effectively in a competitive industry; ability to protect and enhance Advent’s corporate reputation and brand; expectations concerning its relationships and actions with technology partners and other third parties; impact from future regulatory, judicial and legislative changes to the industry; ability to locate and acquire complementary technologies or services and integrate those into the Company’s business; future arrangements with, or investments in, other entities or associations; and intense competition and competitive pressure from other companies worldwide in the industries in which the Company will operate; and the risks identified under the heading “Risk Factors” in Advent’s Annual Report on Form 10-K filed with the Securities and Exchange Commission (“SEC”) on March 31, 2022, as well as the other information filed with the SEC. Investors are cautioned not to place considerable reliance on the forward-looking statements contained in this press release. You are encouraged to read Advent’s filings with the SEC, available at www.sec.gov, for a discussion of these and other risks and uncertainties. The forward-looking statements in this press release speak only as of the date of this document, and the Company undertakes no obligation to update or revise any of these statements. Advent’s business is subject to substantial risks and uncertainties, including those referenced above. Investors, potential investors, and others should give careful consideration to these risks and uncertainties.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220919005463/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

EU Regulatory Reforms and Global Healthcare Innovation to be Focus of DIA Europe 20263.3.2026 13:44:00 CET | Press release

Life science experts will explore AI integration, regulatory transformation, and sustainable access to innovation DIA, a global non-profit organisation of life science professionals, will bring together stakeholders from across Europe and beyond to discuss improving healthcare system efficiency, international collaboration, and recent developments in EU innovation and regulatory frameworks at DIA Europe 2026 (24–26 March, Rotterdam, the Netherlands). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260302327466/en/ EU Regulatory Reforms and Global Healthcare Innovation to be Focus of DIA Europe 2026 As Europe’s leading multistakeholder conference, DIA Europe will bring together over 300 speakers from more than 150 organisations. Participants will include senior representatives from the European Medicines Agency (EMA), the European Commission, national competent authorities, health technology assessment bodies, academia, patien

Visa and Bridge Expand Collaboration, with Plans to Bring Stablecoin-Linked Cards to Over 100 Countries3.3.2026 13:00:00 CET | Press release

Collaboration deepens as Bridge’s stablecoin-linked card program gains global momentum Visa (NYSE:V), a global leader in digital payments, and Bridge, a leading stablecoin infrastructure platform and a Stripe company, today announced an expansion of their global card issuance product that they first unveiled in 2025. Bridge enables businesses and fintech developers to offer stablecoin-backed Visa cards. Now, through Bridge’s partnership with Lead Bank, these card transactions can be settled onchain with Visa. Since launching stablecoin-linked cards, developers using Bridge have rapidly begun offering these Visa cards across the world, enabling consumers to make everyday purchases from stablecoin balances at any of Visa’s 175M+ merchant locations. Bridge-enabled stablecoin-linked cards are now live in 18 countries, with planned expansion to over 100 countries across Europe, Asia Pacific, Africa and the Middle East by end of year. Popular crypto platforms like Phantom and MetaMask are us

AI Is Resetting the Rules of Growth in CPG3.3.2026 13:00:00 CET | Press release

NIQ and Kearney analysis finds challenger brands gaining share as AI reshapes innovation and product discovery NielsenIQ (NYSE: NIQ), a global leader in consumer intelligence, today released The New Growth Frontier. This new analysis, produced in collaboration with Kearney, reveals that artificial intelligence is reshaping how consumer packaged goods (CPG) brands innovate and compete—with profound effects on innovation, product discovery, and consumer path to purchase. Over the past three years, established niche brands increased US market share by 1.5 percentage points (2022–2025), while large and mid-size national brands declined by 2.1 percentage points, according to NIQ retail measurement data across all categories. This data signals a structural shift: Scale remains powerful, but scale is no longer destiny. Competitive advantage increasingly depends on agility, precision, and the ability to surface effectively in AI-mediated discovery environments. “We are entering a precision era

TestGorilla Launches New AI Readiness and AI Fluency Assessments to Help Companies Hire for the Skills That Matter Now3.3.2026 11:34:00 CET | Press release

Seven new AI assessments, built on TestGorilla's five-pillar AI Fluency Framework, give hiring teams a science-backed way to evaluate what resumes can no longer reveal. TestGorilla, the skills-based hiring platform trusted by thousands of organisations worldwide, today announced a suite of new assessments and simulation tests purpose-built to help talent acquisition teams evaluate AI readiness and AI fluency off the back of the company’s flagship event: Hire for the AI Era. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260303398545/en/ Use validated assessments and structured AI video interviews through the TestGorilla platform to measure different aspects of AI fluency across technical and non-technical roles. Inside the platform, tools are clearly labeled with AI fluency making it easy to find and build an assessment. The launch coincides with a crucial shift in the hiring landscape. TestGorilla co-founder and CEO Wouter

Lucidis® Sets High Standards in Premium Cataract Surgery with Full-Range Vision Performance3.3.2026 11:19:00 CET | Press release

Swiss Advanced Vision announces new clinical evidence confirming the exceptional performance of its Lucidis® intraocular lens (IOL), strengthening its position as a disruptive solution in premium cataract surgery. Unlike traditional Extended Depth of Focus lenses, Lucidis® delivers full-range visual performance comparable to a premium trifocal IOL - while preserving contrast sensitivity, visual quality, and minimizing side effects such as halos and glare, hallmarks of its patented fully refractive design. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260303823337/en/ Swiss Advanced Vision premium IOL lenses for cataract surgery A recent peer-reviewed study, Comparative Analysis of Visual Outcomes Between Lucidis 108M (EDOF) and PhysIOL BVI FineVision (Diffractive) IOLs Using Defocus Curve Measurements by H. Naftali, W. Nasser, and M. Naftali, provides compelling comparative data. The findings show that Lucidis® achieves a d

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye